References
- KhoslaSBurrDCauleyJBisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral ResearchJ Bone Miner Res2007221479149117663640
- CardwellCRAbnetCCCantwellMMMurrayLJExposure to oral bisphosphonates and risk of esophageal cancerJAMA201030465766320699457
- ShaneEBurrDEbelingPRAtypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral ResearchJ Bone Miner Res2010252267229420842676
- Park-WyllieLYMamdaniMMJuurlinkDNBisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older womenJAMA201130578378921343577
- MeierRPPernegerTVSternRRizzoliRPeterREIncreasing occurrence of atypical femoral fractures associated with bisphosphonate useArch Intern Med201217293093622732749
- WattsNBBilezikianJPCamachoPMAmerican Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosisEndocr Pract201016Suppl 313721224201
- US Food Drug AdministrationSummary minutes of the joint meeting of the Advisory Committee for Reproductive Health Drugs and Drug Safety and Risk Management Advisory Committee992011 [cited October 8, 2013]. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM278481.pdfAccessed January 27, 2014
- WhitakerMGuoJKehoeTBensonGBisphosphonates for osteoporosis – where do we go from here?N Engl J Med20123662048205122571168
- American Association of Clinical EndocrinologistsAACE Responds to FDA Hearing on Bisphosphonates [cited October 8, 2013]. Available from: http://media.aace.com/press-release/aace-responds-fda-hearing-bisphosphonatesAccessed January 27, 2014
- National Osteoporosis FoundationClinician’s Guide to Prevention and Treatment of OsteoporosisWashington, DCNational Osteoporosis Foundation2013
- DiabDLWattsNBBisphosphonates in the treatment of osteoporosisEndocrinol Metab Clin North Am20124148750622877426
- KanisJAWorld Health Organization Scientific GroupAssessment of Osteoporosis at the Primary Health-Care Level Technical report of the World Health Organization Collaborating Centre for Metabolic Bone DiseasesSheffield, UKUniversity of Sheffield2007
- IMS National Prescription Audit22013
- LookerACMeltonLJ3rdHarrisTBBorrudLGShepherdJAPrevalence and trends in low femur bone density among older US adults: NHANES 2005–2006 compared with NHANES IIIJ Bone Miner Res201025647119580459
- LookerACBorrudLGDawson-HughesBShepherdJAWrightNCOsteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005–2008NCHS Data Brief2012931822617299
- RianonNAnandDRasuRChanging trends in osteoporosis care from specialty to primary care physiciansCurr Med Res Opin20132988188823718160
- NyeAMHamrickIRauchAPoundMWSheltonPSDocumenting the use of calcium supplements with oral bisphosphonatesConsult Pharm201328313823315280
- International Society of clinical Densitometry2007ISCD Official Positions – Adult [cited October 8, 2013]. Available from: http://www.iscd.org/official-positions/2007-iscd-official-positions-adult
- KanisJAJohnellOOdenAJohanssonHMcCloskeyEFRAX and the assessment of fracture probability in men and women from the UKOsteoporos Int20081938539718292978
- SnellingAMCrespoCJSchaefferMSmithSWalbournLModifiable and nonmodifiable factors associated with osteoporosis in postmenopausal women: results from the Third National Health and Nutrition Examination Survey, 1988–1994J Womens Health Gend Based Med200110576511224945